| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514688000 | C=O bonded directly to benzene ring (e.g., acetophenone, etc.) | 21 |
| 20090275666 | CONDENSATION PRODUCTS, METHOD FOR THEIR PRODUCTION AND USE THEREOF IN MEDICAMENTS, AS DISINFECTANTS OR AS A TANNIN - The invention relates to a condensation product obtainable by reaction of
| 11-05-2009 |
| 20090306217 | Method and Compositions - The present invention provides compositions for inhibiting the activity of an insect pest against a subject (or repelling an insect pest from an environment or preventing attraction to an environment) which compositions comprise geranylacetone as an active ingredient plus a carrier plus a further active ingredient selected from the list consisting of: 6-Methyl-hepten-2-one, octanal, plus optional other chemicals. Also provided are related materials and methods of use. | 12-10-2009 |
| 20100273892 | FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES - A formulation, comprising an ophthalmically effective amount of one or more tocotrienol quinones, particularly of alpha-tocotrienol quinone is disclosed. Use of a formulation comprising one or more tocotrienol quinones for the prevention, reduction, amelioration or treatment of ophthalmic disorders that are associated with a neurodegenerative or trauma disorder is also discussed. A method of treating or controlling the ocular symptoms associated with neurodegenerative diseases or trauma with a formulation comprising one or more tocotrienol quinones is also discussed. A method of treating or controlling the ocular symptoms associated with mitochondrial myopathies with a formulation comprising one or more tocotrienol quinones is also discussed. | 10-28-2010 |
| 20120142786 | OREGANO EXTRACT FOR ALERTNESS - extract can act as a stimulant, yet it does not interfere with sleep patterns or induce nervousness the way many stimulants such as caffeine can. It also has the benefits of promoting improved vigilance, improving attention and ability to focus on a task, and improving general alertness. | 06-07-2012 |
| 514689000 | Oxygen single bonded to carbon | 17 |
| 20090054530 | Methods and Compositions that Enhance Bioavailability of Coenzyme-Q10 - Bioavailability of Coenzyme-Q 10 (“Co-Q10”), an oil-soluble substance, can be enhanced in a subject by modifying, e.g. nanonizing or charging, the form of Co-Q10. Co-Q10 bioavailability also can be enhanced by administering Co-Q10 to the subject as an oil (lipid)-based and water (hydro)-based mixed composition, along with other optional components, such as oils, resins and other carriers. Accordingly, the invention provides various Co-Q10 compositions, e.g. compositions comprised of (i) Co-Q10 dissolved in one or more Co-Q10-soluble oils and (ii) Co-Q10 in admixture with at least one water-dispersible agent. A Co-Q10 complex of the invention, therefore, yields an increased cell absorption rate, as well as an enhanced percentage of Co-Q10 peak absorption, compared to previously known compounds. Methods for making and using the aforementioned compositions also are provided. | 02-26-2009 |
| 20090062402 | ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL - A method for the prophylaxis or treatment of inflammatory skin conditions, which method comprises applying to the skin a cosmetic or pharmaceutical preparation comprising licochalcone A and phenoxyethanol. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way. | 03-05-2009 |
| 20090076168 | AMINE-BASED AND IMINE-BASED POLYMERS, USES AND PREPARATION THEREOF - The present invention relates to a modified polysaccharide prepared from the reaction between a polysaccharide comprising a plurality of monosaccharide subunits having at least one primary amino group, and an hydrophobic aldehyde. The aldehyde and the amino group form together an imine or amine group. The process for preparation and use in cosmetic, pharmaceutical and food industry of the modified polysaccharide is also disclosed. | 03-19-2009 |
| 20090111893 | METHOD OF LOWERING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING BLOOD GLUCOSE AND METHOD OF PREVENTING OR TREATING DIABETES AND OBESITY - The compound represented by the general formula (I) is administered to a subject suffering from diabetes or obesity. | 04-30-2009 |
| 20090221715 | NOVEL POLYMORPH OF ATOVAQUONE - The present invention relates to a novel polymorphic form of atovaquone. More particularly, it relates to a novel crystalline form, that has improved solubility and other bulk characteristics suitable for pharmaceutical application. The present invention also relates to processes for preparing a new polymorphic form of atovaquone and its use in industry. | 09-03-2009 |
| 20090270513 | 3,5-DIHYDROXY-2,4-CYCLOHEXADIENONES AND THEIR DERIVATIVES, DIETARY COMPOSITIONS AND FORTIFIED FOOD CONTAINING THEM AND THEIR USES - The present invention refers especially to 3,5-dihydroxy-2,4-cyclohexadienones of the general formula (I) wherein R | 10-29-2009 |
| 20090281196 | 1-ADAMANTYL CHALCONES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - The present invention relates to the compounds of the general formula (I), a composition for and a method of treating breast cancer or other proliferative disorders in a subject using a compound of general formula [I], | 11-12-2009 |
| 20090286884 | Hops Beta-Acid Anti-Diabetic Composition - The invention relates to compositions and processes for reducing the level of blood glucose or ameliorating diabetic symptoms in a subject by treatment with the composition which includes one or more safe and suitable hops acids or hops acid derivatives. More specifically, the process comprises using an ingredient or applying to a food or a nonfood product a composition-comprising beta hops acids in order to reduce blood glucose levels in Type 2 diabetics or its related diseases. | 11-19-2009 |
| 20100048729 | Composition based on xanthoxyline and its use in cosmetic - The present invention relates to the use of xanthoxyline, and of plant extracts containing it, in cosmetic compositions. | 02-25-2010 |
| 20100063161 | TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS - Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein. | 03-11-2010 |
| 20100093869 | SENSATION MASKING COMPOSITION - The present invention provides masking compositions that include a lower alkyl carboxylic acid, e.g. acetic acid. Also provided is a masking composition that includes (a) a lower alkyl carboxylic acid (e.g. acetic acid), a warming sensate (e.g. vanillin or vanillyl butyl ether) and/or a cooling sensate (e.g. menthol or isopulegol). | 04-15-2010 |
| 20100173997 | 2,4,6-TRISUBSTITUTED PHENOLS HAVING ANESTHETIC PROPERTIES - Trisubstituted phenol compounds and methods of using the compounds, e.g., for anesthetizing a subject, are disclosed. | 07-08-2010 |
| 20120115960 | ANIMAL FEED COMPOSITIONS AND FEEDING METHODS - This invention relates to animal feed compositions. The invention also provides comprising a compound of this invention and the use of such compositions in methods of increasing and optimizing feed in animals. | 05-10-2012 |
| 20130109759 | FORMULATIONS OF QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES | 05-02-2013 |
| 20130116336 | TREATMENT OF ATAXIA TELANGIECTASIA - The present invention relates to methods of treating Ataxia-Telangiectasia (A-T) or Ataxia-telangiectasia like disorder (ATLD) with compounds such as tocotrienol quinones and tocotrienol hydroquinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease. | 05-09-2013 |
| 20140066519 | USE OF XANTHOHUMOL AND/OR ISOXANTHOHUMOL AS AN AGENT FOR PREVENTING AND/OR COMBATING LIVER DISEASES - Method for the prevention and/or control of liver diseases, such as non-alcoholic steatohepatitis (NASH) even when eating a high fat diet. Prevention of NASH can be accomplished by preventing the liver from becoming a fatty liver even when eating a high fat diet by providing xanthohumol as a supplement to the high fat diet. | 03-06-2014 |
| 20140142194 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES - The present invention provides methods and compositions for treating neurodegenerative diseases by cyclohexenone compounds. | 05-22-2014 |
